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SUMMARY
Cellular barcoding and other single-cell lineage-
tracing strategies form experimental methodologies
for analysis of in vivo cell fate that have been instru-
mental in several significant recent discoveries. Due
to the highly nonlinear nature of proliferation and
differentiation, interrogation of the resulting data for
evaluation of potential lineage pathways requires a
new quantitative framework complete with appro-
priate statistical tests. Here, we develop such a
framework, illustrating its utility by analyzing data
from barcodedmultipotent cells of the blood system.
This application demonstrates that the data require
additional paths beyond those found in the classical
model, which leads us to propose that hematopoietic
differentiation follows a loss of potential mechanism
and tosuggest further experiments to test this deduc-
tion. Our quantitative framework can evaluate the
compatibility of lineage trees with barcoded data
from any proliferating and differentiating cell system.
INTRODUCTION
Cell lineage-tracing techniques are powerful tools to study
development, tissue maintenance, and repair. They aim to deci-
pher lineage pathways and to understand cell-fate decisions.
Cellular barcoding is an in vivo lineage tracing technique for
simultaneously determining the fate of the progeny of multiple
initial cells. Extending pioneering approaches that rely on retro-
viral tagging (Lemischka et al., 1986; Lemischka, 1992), it labels
cells with a unique and heritable genetic barcode enabling the
identification of familial relationships in progeny (Figure 1A).
Fluorescent markers and cell surface markers have also been
utilized to follow the output of individual cells (Kretzschmar and
Watt, 2012; Livet et al., 2007; Snippert et al., 2010; Buchholz
et al., 2013). Cellular barcoding has recently led to significant dis-
coveries in fields such as immunology, hematopoiesis, and can-
cer (Schepers et al., 2008; van Heijst et al., 2009; Gerrits et al.,
2010; Lu et al., 2011; Kreso et al., 2013; Naik et al., 2013). Data
from continuously self-renewing stem cells typically reveal domi-
nance of a small number of stem cells, providing little information
on the downstream structure of the lineage pathway (Lu et al.,
2011; Naik et al., 2013; Grosselin et al., 2013; Verovskaya
et al., 2013). In contrast, cellular barcoding data frommultipotent
progenitors (MPPs) have revealed substantial heterogeneity in
the proliferation and differentiation outcomes of apparently iden-
tical cells (Naik et al., 2013) and have greater utility for lineage
pathway inference.
Although substantial development of the experimental
methodology has taken place, a framework for mathematical
modeling and statistical testing is required to draw quantitative
inferences about the underlying proliferation and differentiation
processes. In particular, identification of lineage pathways
from cellular barcoding data is fraught with difficulty because
the nonlinear dynamics of proliferation and differentiation
mislead intuitive deductions. We developed such a quantitative
framework for multipotent cells based on transient multitype
branching processes, which enabled us to capture the heteroge-
neity of individual cell fates. The framework identifies the best-fit
parameters for any given lineage pathway structure and queries
whether the resulting model is statistically consistent with the
data. Pathways that are inconsistent with the data are identified
and rejected.
We applied this framework to our previously published data
from the hematopoietic system (Naik et al., 2013), which has
emerged as a model system to study stem cell development
(Orkin and Zon, 2008). Hematopoiesis describes the continuous
formation of blood cells, which are grouped into two broad line-
ages: the lymphoid and myeloid lineage. Results from hemato-
poietic research have been applied in stem cell transplantation
to cure blood cell deficiencies caused by irradiation, chemo-
therapy, and genetic defects (Weissman, 2000). Despite its clin-
ical successes, the hematopoietic pathway of cell differentiation
remains poorly understood.
In themost commonly held model of hematopoiesis, which we
call the classical model, hematopoietic stem cells (HSCs) self-
renew and generate progenitors that differentiate and produce
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all blood cells. Immediate progenitors of a HSC lose their self-
renewal capacities but remain multipotent (Adolfsson et al.,
2001; Morrison et al., 1997). These MPPs commit to two sepa-
rate branches, becoming either common lymphoid progenitors
(CLPs) or common myeloid progenitors (CMPs) (Akashi et al.,
2000; Kondo et al., 1997; Reya et al., 2001). CLPs give rise to
further committed progenitors that produce lymphoid cells,
such as T and B lymphocytes and natural killer (NK) cells,
whereas CMPs give rise to progenitors that produce granulo-
cytes and monocytes (GMPs), among others, and progenitors
that only produce megakaryocytes and erythrocytes (MEPs).
Dendritic cells, another group of blood cells, derive from both
CLPs and GMPs (Manz et al., 2001; Traver et al., 2000). Not all
available data, however, appear consistent with the classical
model (Graf, 2008; Kawamoto and Katsura, 2009). For example,
in contrast to the presumed myeloid and lymphoid origin of den-
dritic cells, our recent cellular barcoding data (Naik et al., 2013)
from lymphoid-primed multipotent progenitors (LMPPs) (Adolfs-
son et al., 2001, 2005) established that many LMPPs produced
dendritic cells without generating detectable lymphoid and
myeloid output, leading us to propose that dendritic cells should
be considered a separate lineage of hematopoiesis.
As an illustration of the power of our framework, we used it to
test potential hematopoietic lineage pathways for consistency
with barcode-labeled LMPPs (Naik et al., 2013). We found that
the distribution of cell types generated by LMPPs was statisti-
cally consistent across mice, suggesting that the hematopoietic
pathway is mouse independent. Furthermore, we found that the
data are incompatible with a quantitative interpretation of the
classical model. Rather, this analysis provides evidence for addi-
tional differentiation paths beyond those found in the classical
model, leading us to propose a revised model of the hematopoi-
etic pathway. In this model, hematopoietic differentiation follows
a loss of potential mechanism that is proportionally equal at
every step of differentiation.
More generally, the quantitative framework is suitable for the
analysis of transient multipotent, proliferating, and differentiating
cells utilizing any single-cell lineage tracing methodology.
RESULTS
The Quantitative Framework
The framework includes binarization of the cellular barcoding
data as well as the development and analysis of a stochastic
model for drawing inference on lineage pathways. For each line-
age pathway, best-fit model results are compared to data with a
statistical test. Lineage pathways that are consistent with the
data are simulated to garner information on the dynamic proper-
ties of proliferation and differentiation and to test for confidence
in parameter fits.
The quantitative framework for drawing inferences on lineage
pathways begins with recording the presence or absence of
each barcode in each cell type, a process that we call binariza-
tion (Figure 1A). The reasons for this binarization are 3-fold: (1)
due to nonlinearities in PCR amplification for the low-abundant
barcodes (see Figure S2 of Naik et al., 2013), cell counts are at
best semiquantitative; (2) not all cells in the animal are investi-
gated for their barcodes, and the binarized data are more robust
to this sampling; and (3) binarization has the advantage that the
proliferation of the final cell types need not be modeled.
A B
C
Figure 1. Binarizing Cellular Barcoding Data
and Possible Lineage Pathways
(A) In cellular barcoding experiments, progenitors
are transduced so that each receives a unique,
heritable DNA barcode. After proliferation and dif-
ferentiation, progeny of the barcoded progenitors
are isolated from the bone marrow and the spleen
and analyzed for their barcode repertoire by deep
sequencing. The myeloid cell group consisted of
neutrophils and monocytes measured in the bone
marrow and the spleen, the dendritic cell group
consisted of CD8+ dendritic cells and plasmacy-
toid dendritic cells measured in the spleen, and the
B cells were measured in the bone marrow and the
spleen. The data obtained from deep sequencing
are then binarized to identify the cell types in which
the barcode was recovered.
(B) In the general tree, multipotent progenitors can
divide or differentiate by losing the potential to
generateoneor twocell types,asshownby thearrow
associated with the name of the probability of the
event. The letters of their name encode their cell type
potentials; for example, anMDBcell has thepotential
to generatemyeloid cells, dendritic cells, andB cells.
(C) Theclassical tree isaquantitative interpretationof
the classical model and is a restriction of the general
tree with the probability to lose the dendritic cell
potential at the MDB stage and the probability of
losing two potentials simultaneously set to zero. MD
and DB represent respectively the myeloid and
lymphoid branches.
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Because the output from apparently identical cells consis-
tently exhibits heterogeneity (Snippert et al., 2010; Kaech and
Wherry, 2007; Gerlach et al., 2013; Buchholz et al., 2013; Duffy
et al., 2012; Gomes et al., 2011; Rieger and Schroeder, 2008;
Hasbold et al., 2004; Shortman and Naik, 2007), a stochastic
approach was chosen to encapsulate this diversity. Random-
ness acts as a proxy for the uncertainty in outcome regardless
of whether the source is the execution of truly stochastic prolif-
eration and differentiation programs or due to an unidentified
heterogeneity in the initial barcoded cohort. The stochastic
model is based on a multitype, transient branching process
that captures potency restrictions due to differentiation (see
Experimental Procedures).
The model begins with the definition of a lineage pathway
structure that encodes the differentiation outcomes that are
possible. When cells differentiate, they lose the potential to
make one or more cell types. Within the model, each cell is
assumed to proliferate or differentiate independently of all other
cells with a probability that depends upon its current potential-
ities. This process of division and differentiation from a barcoded
progenitor ends when each of its progeny are left with the poten-
tial to produce only one cell type. With regards to both intuition
and mathematical analysis, it is this proliferation that is the
primary confounding factor.
The model quantifies a given lineage pathway by a set of
probabilistic parameters. From this we determined explicit math-
ematical expressions for the probability that a barcoded progen-
itor produces a given binarized output, which facilitates the fitting
of the model to the data. The maximum likelihood best-fit model
to data is identified by computer-optimization and compared
to the cellular barcoding data via a statistically consistent like-
lihood-ratio multinomial test that determines if the pathway is
rejected by the data. If a lineage pathway with its best-fit param-
eters is statistically inconsistent with the data, then it is rejected.
Although the mathematical model provides explicit formulae
for any finite number, N, of final cell types, the ability to reject a
network depends on the quantity and nature of the data. If
cellular barcoding experiments were performed for N cell types,
then each barcode can be recovered in one of 2N  1 combina-
tions. Due to the nonlinear dynamics of the model, the statistical
power is, however, a function not only of N but also of the struc-
ture of the empirical multinomial obtained from the data. As a
result, we advocate that for a given pathway structure of interest,
random sets of binarized outcomes should be independently
simulated from the data and the model refit to each set to deter-
mine the consistency of parameter estimates.
A typical limitation of cellular barcoding experiments is that an-
imals must be sacrificed, so there is no time-course data. For the
best-fit model parameters, a simulation of the lineage pathway
can identify timescales within the model in terms of generations
(rounds of proliferation). This quantifies the dynamics of events
within the model, which can be compared with what is physio-
logically known.
Cellular Barcoded LMPPs
As application of the framework is most readily understood by
example, we consider its use for data from the hematopoietic
system. From the data that we published in (Naik et al., 2013)
for barcoded LMPPs, we categorized the final cell types as
being of the myeloid (M), dendritic (D), or B cell (B) families
and binarized the output of individual barcodes (Figure 1A).
The general tree (Figure 1B) encapsulates the lineage pathway
of a barcoded LMPP, which has the potential to make M, D,
and B cells, with all possible links. Within this framework, our
quantitative interpretation of the classical model of hematopoi-
esis, which we call the classical tree, is a restriction of the gen-
eral tree such that the initial progenitors are incapable of losing
dendritic cell potential (Figure 1C). This restriction is consistent
with the early separation between lymphoid and myeloid
branches, and the myeloid and lymphoid origin of dendritic cells
in the classical model (Akashi et al., 2000; Kondo et al., 1997;
Traver et al., 2000; Manz et al., 2001). The framework assumes
that individual cell fates are chosen independently so that no
feedback mechanism exists between a cell’s state and any
other’s. In addition, we assume that the cellular barcoding
data are the result of final differentiation events. This hypothesis
seems sound because the heterogeneity of LMPPs has been re-
ported not to dramatically change when assessed on different
days (Naik et al., 2013).
Progeny of 978 distinct barcoded LMPPs were identified in
four wild-type mice. As reported previously, individual LMPPs
were not all multioutcome, but instead LMPPs produced hetero-
geneous patterns of limited types of blood cells (Figure 2A). The
offspring of a single barcoded LMPP cell can be found in one of
seven possible combinations of cell categories (M, D, B, M+D,
M+B, D+B, or M+D+B), depending on the cell types it produced.
The proportion of barcodes recovered in each combination
of cell types did not show statistically significant differences
between mice (Figure 2B and multinomial test in Table 1). This
consistency across mice suggests that the lineage pathway
is not a mouse-specific property and justifies pooling the data
when considering model fits. Thus, it was appropriate to use
our quantitative framework to identify hematopoietic lineage
pathways that can explain this data.
Inferring LMPP Lineage Pathways
We first assessed whether the classical tree (Figure 1C) was
consistent with the data. When the six best-fit probabilities of
division and differentiation of the classical tree were determined,
we obtained visual similarity between the cellular barcoding data
and the fit (Figure 2C). The multinomial test, however, showed
significant differences (Table 1), strongly rejecting the hypothesis
that the classical tree can account for the heterogeneous out-
comes observed. The best-fit model to the pooled data was
checked against the barcodes taken from each individual mouse
and was also rejected as being inconsistent (Table 1). The clas-
sical tree does not describe the cellular barcoding data because
the prevalence of progenitors producing both myeloid and
lymphoid cells without producing dendritic cells (M+B) cannot
be made consistent with the number that generate only one of
the cell types B or M without D (Table S1). Note that in the clas-
sical tree, few progenitors can give rise to myeloid and lymphoid
cells without producing dendritic cells. If a progenitor divides at
least once before engaging in both the lymphoid (DB) and
myeloid (MD) branches, it will most likely produce dendritic cells
due to the large numbers of progenitors producing only dendritic
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cells. This property of the classical tree can be establishedmath-
ematically for any paramerization of its links (Supplemental
Experimental Procedures).
To test the robustness of our conclusions to potential contam-
ination or detection issues, we applied a range of barcode
abundance thresholds for the binarization. As a consequence,
a barcode that had a read-count below the threshold in a given
cell type is not recorded as present in that cell type (Supple-
mental Experimental Procedures). The percentage of barcodes
in each category is not dramatically changed upon application
of these different thresholds (Figure S1). When refitted to the
new thresholded data, the classical model is only no longer re-
jected after the least-abundant 37% barcodes are eliminated
(Figure S2), adding confidence that our conclusions are robust
to potential contamination or detection issues.
Another possible caveat to our rejection of the quantitative
interpretation of classical model is that we cannot exclude that
the high proportion of progenitors that produce only dendritic
cells was due to the effect of irradiation and may not represent
the physiological situation. This, however, doesn’t change our
deduction, because the classical model was itself derived from
experiments in irradiated recipient mice (e.g., for the identifica-
tion of the lymphoid and myeloid progenitor [Akashi et al.,
2000; Kondo et al., 1997]).
Removing the restrictions of the classical tree (Figure 1B) and
repeating the fitting procedure for the general tree produces a
fit that is consistent with the cellular barcoding data (Table 1),
indicating that additional differentiation paths are necessary
to explain the data. Importantly, no other lineage pathway struc-
ture than the general tree is consistent with the cellular barcoding
data, because deleting any of the links of the general tree and
refitting the corresponding pathway resulted in significant
statistical differences (Table 2). Nevertheless, the general tree,
which has 12 parameters (4 proliferation and 8 differentiation
Figure 2. Application of the Framework to
Barcoded Multipotent Progenitors Data
(A) For one representative mouse, the heatmap
shows the binarized output of individual barcoded
multipotent progenitors (LMPP in the rows) to
the three different cell types (in the columns). The
clustering is done using complete linkage and
Manhattan distance. Red indicates the presence of
the barcode in the cell type and black its absence.
(B) Proportions of progenitors in each of the seven
possible combinations of cell types for each of the
four mice (with, respectively, 292, 273, 244, and
169 individual barcoded LMPPs).
(C) Sameas (B) but for the pooled data from the four
mice, for the maximum-likelihood fit values of the
classical tree and the equal loss of potential (ELP)
model. Using a multinomial test, the best-fit clas-
sical tree is rejected (p = 1010), but not the ELP
model (p = 1). The 95%confidence intervals, based
onanormal approximation, areshownaserror bars.
probabilities), is overparameterized, with
several equally good combinations found
during fitting. Consequently, we looked
for a biologically plausible alternative that includes all the links
but reduces the number of parameters.
Equal Loss of Potential
Several aspects of hematopoietic differentiation have already
been modeled using branching processes, such as self-renewal
of stem cells (Till et al., 1964; Nakahata et al., 1982; Macken and
Perelson, 1988) and proliferation and differentiation of MPPs
(Tsuji and Nakahata, 1989; Kurnit et al., 1985), although not for
the purpose of lineage pathway identification. While studying
hematopiesis with in vitro assays, Ogawa and coworkers
(Ogawa et al., 1983; Tsuji and Nakahata, 1989) proposed a
model where each cell loses each potential with a fixed probabil-
ity, irrespective of its current cell type. Based on that intuitive
biological principle, we developed a parameterization of the
general tree, which we call the equal loss of potential (ELP),
that is suitable for the additional difficulties of binarized in vivo
cellular barcoding data where proliferation is not directly
observed and proliferation rates of different cell types are al-
lowed to be distinct.
In the ELP model, the lineage pathway retains all of the tran-
sitions of the general model (Figure 1B) but strictly couples the
transition probabilities by insisting that the probability of losing
a potential to produce a certain cell type (M, B, or D) remains
proportionally equal at every step of differentiation (Figure 3A;
Experimental Procedures). The number of parameters is thus
reduced to seven: four division probabilities and three loss-of-
potentiality rates. The fit obtained from this model didn’t
show significant differences with the data (Figure 2C; Table 1;
Table S1) and is not rejected with a multinomial test. Interest-
ingly, the by-far most probable paths obtained from the ELP
fit, starting from MDB cells, are to the lymphoid (DB) and
myeloid (MD) branches, drawing a lineage pathway whose
main initial routes are akin to those of the classical tree
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(Figure 3B). The primary quantitative differences between the
best-fit classical tree and the best ELP model are the addition
of a rare MB progenitor and the infrequent loss of two potenti-
alities simultaneously. The small contribution of the additional
transitions is a possible explanation for their rareness in the
data that led to the classical model.
Simulation of Cellular Barcoding Data
As is typically the case with cellular barcoding data, we have no
time-course data and so no estimates of cell lifetimes. Monte
Carlo simulation of the best-fit lineage pathway showed that
the number of rounds of proliferation until barcoded LMPPs pro-
duce their committed cell types is of the order of 20, a value that
would allow the process to be completed before the mice were
sacrificed after 2 weeks. An example of the generational time
course of one such simulated experiment is shown in (Figure 3C).
The stochastic nature of the framework leads to significant het-
erogeneity in repeated simulations with a single LMPP, but pop-
ulation level consistency through the law of large numbers.
To test if the 978 barcodes are sufficient for the population-
level consistency, we generated simulated sets of four mice us-
ing the best-fit equal loss of potential model, mimicking the
experimental data. These simulated data are statistically indis-
tinguishable from their experimental counterpart (Figure 3D).
The ELP model was fitted to these simulated data and the
best-fit parameters were consistent across fits, giving an indica-
tion of their robustness (Figure S3). We repeated this procedure
with different numbers of recovered barcodes (Figure S3). The
results indicate that for the seven categories of barcoded LMPPs
outcome, recovery of approximately 500 barcodes is sufficient
to build a clear statistical image in the quantitative framework.
DISCUSSION
The application of our quantitative framework to data from
the hematopoietic development reveals surprising features that
result in experimentally testable predictions. The statistical con-
sistency that was found acrossmice, despite per-progenitor het-
erogeneity, suggests that the lineage pathway is a robust feature
(Figure 2B). Repeating these experiments in other mouse strains
would aid in the identification of genetic sources of variability
in hematopoietic development. If the distributions between the
categories of progenitors are statistically indistinguishable in
distinct strains, then it would suggest that much of the lineage
pathway is determined from conserved or intrinsic properties
of the progenitors and not heavily influenced by the environment.
If, instead, the distribution is inconsistent across mouse strains
but identical within them, then this would aid in the identification
of significant fate factors. These perturbing factors would need
to be described and characterized and would inform further
experimentation.
Lineage pathway inference establishes that additional links
beyond those in the classical model are necessary to explain
the data from Naik et al. (2013). Due to the prevalence of sin-
gle-outcome dendritic cell progenitors in Naik et al. (2013), we
previously deduced that dendritic cells form a separate lineage.
Results from the quantitative framework suggest that many of
the single-outcome dendritic cell progenitors arise through inter-
mediate MPPs (MD or DB) that only give rise to dendritic cells.
Motivated by a biologically meaningful process, the equal loss
of potential at every step, we propose a hematopoietic lineage
pathway that includes all possible links. Note that the best-
fit pathway subject to that constraint possesses the strong
myeloid-lymphoid split of the classical model but with essential,
albeit less frequently observed, links that could have proved diffi-
cult to observe in experiments on populations of cells.
Even though the ELP model gives results in accordance with
the cellular barcoding data, one cannot deduce that proliferation
and differentiation are genuine stochastic processes, because
the results from the ELP model can be interpreted in at least
two ways. If the model reflects truly stochastic proliferation
and differentiation, then it predicts that all the intermediate cell
states of differentiation described in the general tree should be
identifiable downstream of LMPPs. The identification of single-
outcome progenitors for the lymphoid lineage in the population
of MPPs (Medina et al., 2001; Lai et al., 2005) is consistent
with this prediction. Other types of progenitors that derive
Table 2. Multinomial Test Result for the Pathway with Each
Single Link Removed
Link p Value Likelihood Ratio
pMDB 0 infinity
pMDB/M 7.5 3 1011 58.89
pMDB/D 7.5 3 1011 58.89
pMDB/B 7.5 3 1011 58.89
pMDB/MD 0 118.1
pMDB/MB 7.5 3 1011 58.89
pMDB/DB 0 91.36
pMD 0 118.1




pMB/M 7.5 3 1011 58.89
pMB/B 7.5 3 1011 58.89
pDB/D 0 89.56
pDB/B 0 90.81















NA 7.5 3 1011 1 1
Mouse 1 0.19 0.02 0.0008 0.19 0.19
Mouse 2 0.71 0.05 0.0399 0.71 0.70
Mouse 3 0.53 0.03 0.0280 0.53 0.53
Mouse 4 0.04 0.01 6 3 107 0.04 0.04
NA, not applicable.
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directly from MPPs, such as single-outcome dendritic cells and
bioutcome MB progenitors, could then also be identified. If
instead the ELP were to encapsulate lineage priming in the initial
barcoded cohort that is already present before major clonal
expansion, then the model predicts the frequency of occurrence
of each unidentified primed state. Another way to test the ELP
model further would be to increase the number of cell types
recovered, for example by adding erythrocytes. One could
then reuse the framework to determine whether the extended
data are still consistent with the ELP model.
Although the application of our framework to barcoded he-
matopoietic MPPs demonstrates the method’s utility and power,
it is suitable for the study of any single-cell lineage tracing meth-
odology, from multipotent, transient, proliferating, and differenti-
ating cells. Our framework may prove instrumental for lineage
pathway inference in other systems of tissue development, such
as those found in the development of the breast and intestine
in homeostasis or cancer (Barker et al., 2008; Visvader, 2009).
EXPERIMENTAL PROCEDURES
Introduction
The framework is suitable for initially multipotent cells that have any finite num-
ber of potential fates, but for clarity we present it for three final fates. This
setting reveals all of the complexity of the approach while being sufficient for
the analysis of the experimental data described in the main text.
Consider a cohort of initially multipotent cells that can produce cells of type
M, D, and B (shorthand for myeloid, dendritic, and B cells). Each initial cell is of
type MDB, indicating it has all three potentials, whereas subsequent cells can
be of type MDB, MD, MB, DB, M, D, or B. For example, a cell of type MD could
produce cells of types M and D but has lost the B potential. A barcode initially
placed in an MDB cell can ultimately be found in one of seven combinations:
cells of only one type (M, B, D), cells of two types (M+B, M+D, D+ B), or cells
of all three types (M+B+D). For the application to hematopoiesis, because the
mice have been irradiated and are being reconstituted, we assume that cells
proliferate and differentiate but do not die before becoming final cell types.
For alternate applications, one can readily include an additional state corre-
sponding to dead cells.
Overview of the Stochastic Model
As depicted in Figure 1B, the general tree allows the loss of any number or
combination of potentials at any stage. For example, a cell of type MD can
become a cell of type M or D. Starting with an initial cell of type MDB, letting
NM, ND, and NB denote the number of offspring of each type produced by
that cell, we are interested in knowing properties of the joint probability
mass function P(NM = m, ND = d, NB = b) for all m, d, b in {0,1,2,...}. For any
parameterization of the general tree, Equation S2 in Supplemental Experi-
mental Procedures identifies an explicit expression for the Laplace transform








B PðNM =m; ND =d; NB =bÞ;
(Equation 1)
where sM, sD, and sB are elements of the real line. From this, we deduce explicit
expressions for the likelihood that a given barcode appears in cells of type M,
D, B, M+D, M+B, D+B, or M+D+B, which is crucial in enabling us to find the
parameters that provide the best fit to data.
Maximum-Likelihood Fitting Procedure
Denote the vector of 12 transition probabilities of the model by
p= ðpMDB; pMD; pMB; pDB; pMDB/MD; pMDB/MB; pMDB/DB;
pMDB/M; pMDB/D; pMDB/B; pMD/M; pMB/B; pDB/DÞ:
Using the expressions for the probabilities of barcoded outcomes in
Table S2 and the function fmincon from the Optimization Toolbox of Matlab
R2011a, we determine the maximum likelihood parameters of the model by
solving the following optimization problem
pmax = arg maxpðnM+D+B log pM+D+BðpÞ+ nM+D log pM+DðpÞ
+ nM+B log pM+BðpÞ+ nD+B log pD+BðpÞ
+ nM log pMðpÞ+ nD log pDðpÞ+ nB log pBðpÞÞ;
(Equation 2)
where nM+D+B is the number of barcodes observed to produce M+D+B and
pM+D+B(p) is the probability that, given the lineage pathway is parameterized
with p, a barcode results in cells of all three types, and so forth for the other six
potential outcomes (see Table S2). In this fitting procedure, we can restrict to
A B
C D
Figure 3. The Equal Loss of Potential Model
(A) The equal loss of potential (ELP) model has all of
the links of the general model, but its transition
probabilities are constrained: the probability of
losing a potential to produce a certain cell type
(M, red; B, blue; or D, green) remains proportionally
equal at every step of differentiation, which is illus-
trated by use of the same color. The probability to
lose two potentials at the same time is the product of
the probability of losing each of the potentials.
(B) The best-fit value of the probabilities computed
from the seven parameters of the ELP model.
(C) Using the best-fit values from (B), a mouse
with 300 barcoded MDB cells was simulated. The
number of barcodes at each stage of the pathway at
each round of division (generation) is shown.
(D) Similar to Figure 2B, the proportions of pro-
genitors in each of the seven possible combinations
of cell type are shown for four simulated mice with
the same number of individual barcoded pro-
genitors detected (292, 273, 244 and 169 respec-
tively). Standard deviations are shown as error bars.
These simulated mice are statistically consistent
with the experimental mice, indicating the suffi-
ciency of the data.
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any pathway by insisting that the probability of disallowed transitions are set to
zero.
Evaluating Fits via a Multinomial Test
Having identified the best-fit parameters for a given pathway, pmax, in Equation
2, we use a consistent multinomial test based on a log likelihood ratio to deter-
mine whether the pathway is inconsistent with the data. Namely, letting
n= nM+D+B + nM+D + nM+B + nD+B + nM + nD + nB
be the total number of barcodes recovered, we evaluate twice the log likeli-
hood ratio,
2ðnM+D+B=n logðnM+D+B=ðn pM+D+BðpmaxÞÞÞ
+ nM+D=n logðnM+D=ðn pM+DðpmaxÞÞÞ
+ nM+B=n logðnM+B=ðn pM+BðpmaxÞÞÞ
+ nD+B=n logðnD+B=ðn pD+BðpmaxÞÞÞ
+ nM=n logðnM=ðn pMðpmaxÞÞÞ
+ nD=n logðnD=ðn pDðpmaxÞÞÞ+ nB=n logðnB=ðn pBðpmaxÞÞÞÞ;
where the p are the probabilities in Table S2 for the best-fit parameters deter-
mined from Equation 2. For a sufficiently large number of recovered barcodes,
n, because the model has seven mutually exclusive potential outcomes, we
use a c2 test with six degrees of freedom. Note that the maximum likelihood
fit to the data minimizes this c2 value, so that the best-fit parameter for a given
pathway structure is the one that minimizes the likelihood we will reject the
pathway given the data.
The ELP Model
The ELP model retains all links of the general tree but reduces the number of
parameters from 12 to seven by strictly coupling transition probabilities
through a biologically motivated means. We assume that irrespective of
current cell type there is a rate of loss of each of the three potentialities a =
(aM, aD, aB), which are all nonnegative real numbers. The transition probabili-
ties of the models are written in terms of these so that, for example, the
probability that an MDB cell loses its B potential is
pMDB/MDðaÞ= aB=ðaM +aD + aB +aMaD +aMaB +aDaBÞ;
whereas the probability that an MDB cell loses both its D and B potentials is
pMDB/MðaÞ= ðaB +aDÞ=ðaM +aD + aB +aMaD +aMaB +aDaBÞ
and the probability that an MD cell loses both its D potential is
pMD/MðaÞ=aD=ðaM +aDÞ:
These rules are consistently applied across all cell types and correspond to
a notion of approximately autonomous processes underway in each cell lead-
ing to the loss of each potential.
Simulation
Given the best-fit ELP model, we implemented a stochastic simulation in
MATLAB that follows precisely the rules of the model. Although themathemat-
ical fits are determined by the final outcome of the proliferation and differenti-
ation processes, the simulation enables us to investigate the per-generation
(i.e., per-division) transient process, giving an indication as to the consistency
of themodel time frame with the data time frame. One typical sample of the cell
types produced by 300 barcodes as a function of generation is presented in
Figure 3C, illustrating that the process completes within a biologically reason-
able number of generations.
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